202 related articles for article (PubMed ID: 15069015)
1. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.
van de Geijn GJ; Gits J; Aarts LH; Heijmans-Antonissen C; Touw IP
Blood; 2004 Aug; 104(3):667-74. PubMed ID: 15069015
[TBL] [Abstract][Full Text] [Related]
2. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.
Hunter MG; Jacob A; O'donnell LC; Agler A; Druhan LJ; Coggeshall KM; Avalos BR
J Immunol; 2004 Oct; 173(8):5036-45. PubMed ID: 15470047
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1.
Zhuang D; Qiu Y; Haque SJ; Dong F
J Leukoc Biol; 2005 Oct; 78(4):1008-15. PubMed ID: 16033816
[TBL] [Abstract][Full Text] [Related]
4. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
[TBL] [Abstract][Full Text] [Related]
5. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
6. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.
Ward AC; van Aesch YM; Schelen AM; Touw IP
Blood; 1999 Jan; 93(2):447-58. PubMed ID: 9885206
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation.
Dong F; Qiu Y; Yi T; Touw IP; Larner AC
J Immunol; 2001 Dec; 167(11):6447-52. PubMed ID: 11714811
[TBL] [Abstract][Full Text] [Related]
8. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells.
Hermans MH; van de Geijn GJ; Antonissen C; Gits J; van Leeuwen D; Ward AC; Touw IP
Blood; 2003 Apr; 101(7):2584-90. PubMed ID: 12468431
[TBL] [Abstract][Full Text] [Related]
9. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
Qiu Y; Zhuang D; MacRae A; Dong F
Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.
Ward AC; Hermans MH; Smith L; van Aesch YM; Schelen AM; Antonissen C; Touw IP
Blood; 1999 Jan; 93(1):113-24. PubMed ID: 9864153
[TBL] [Abstract][Full Text] [Related]
11. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling.
Kimura A; Kinjyo I; Matsumura Y; Mori H; Mashima R; Harada M; Chien KR; Yasukawa H; Yoshimura A
J Biol Chem; 2004 Feb; 279(8):6905-10. PubMed ID: 14699146
[TBL] [Abstract][Full Text] [Related]
12. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
[TBL] [Abstract][Full Text] [Related]
13. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation.
de Koning JP; Dong F; Smith L; Schelen AM; Barge RM; van der Plas DC; Hoefsloot LH; Löwenberg B; Touw IP
Blood; 1996 Feb; 87(4):1335-42. PubMed ID: 8608222
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor.
Dong F; Liu X; de Koning JP; Touw IP; Hennighausen L; Larner A; Grimley PM
J Immunol; 1998 Dec; 161(12):6503-9. PubMed ID: 9862674
[TBL] [Abstract][Full Text] [Related]
15. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
Chakraborty A; Dyer KF; Tweardy DJ
Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
[TBL] [Abstract][Full Text] [Related]
16. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
Boyle K; Egan P; Rakar S; Willson TA; Wicks IP; Metcalf D; Hilton DJ; Nicola NA; Alexander WS; Roberts AW; Robb L
Blood; 2007 Sep; 110(5):1466-74. PubMed ID: 17510322
[TBL] [Abstract][Full Text] [Related]
17. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.
Peltola KJ; Paukku K; Aho TL; Ruuska M; Silvennoinen O; Koskinen PJ
Blood; 2004 May; 103(10):3744-50. PubMed ID: 14764533
[TBL] [Abstract][Full Text] [Related]
18. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.
Dror Y; Ward AC; Touw IP; Freedman MH
Exp Hematol; 2000 Dec; 28(12):1381-9. PubMed ID: 11146160
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
[TBL] [Abstract][Full Text] [Related]
20. G-CSF receptor mutations in patients with severe congenital neutropenia do not abrogate Jak2 activation and stat1/stat3 translocation.
Herbst A; Koester M; Wirth D; Hauser H; Welte K
Ann N Y Acad Sci; 1999 Apr; 872():320-5; discussion 325-7. PubMed ID: 10372134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
